Paris-based life sciences focused investment firm Kurma Life Sciences Partners has hired biotech and pharmaceutical industry veteran Vanessa Malier as a partner.
Prior to joining Kurma, Malier, pictured, served as a vice president of research and development and strategic planning at Ipsen.
She has also worked for venture capital firm CDC Innovation and California-based startup Drug Abuse Sciences.
Kurma said in a statement, “Vanessa will add a strong operational background to the team, and will reinforce Kurma Life Sciences Partners positioning as an active investor operating in the field of life sciences in Europe, few months after the launch of Kurma Biofund II, the first venture capital fund dedicated to financing innovation in the rare diseases space.”
Kurma’s new fund has been backed by Idinvest Partners alongside CDC Entreprises, GSK and NEA.
Founded in July 2009, KLS Partners provides venture capital, development capital and technology transfer in the life sciences space, including biotechnologies, health, nutrition, environmental sciences.
Copyright © 2013 AltAssets